Business Description
Scilex Holding Co
NAICS : 325411
SIC : 2834
ISIN : US80880W1062
Description
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -1.71 | |||||
| Debt-to-Equity | -0.74 | |||||
| Debt-to-EBITDA | -1.24 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -12.21 | |||||
| Beneish M-Score | -7.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.6 | |||||
| 3-Year EBITDA Growth Rate | -53.6 | |||||
| 3-Year EPS without NRI Growth Rate | -52 | |||||
| 3-Year FCF Growth Rate | 12.1 | |||||
| 3-Year Book Growth Rate | -17.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.59 | |||||
| 9-Day RSI | 24.32 | |||||
| 14-Day RSI | 27.27 | |||||
| 6-1 Month Momentum % | -21.35 | |||||
| 12-1 Month Momentum % | -79.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.17 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 69.45 | |||||
| Days Sales Outstanding | 185.96 | |||||
| Days Payable | 480.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 9.1 | |||||
| Shareholder Yield % | -59.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.45 | |||||
| Operating Margin % | -225.56 | |||||
| Net Margin % | -244.6 | |||||
| FCF Margin % | -44.3 | |||||
| ROA % | -118.88 | |||||
| ROIC % | -95.46 | |||||
| ROC (Joel Greenblatt) % | -3537.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.37 | |||||
| EV-to-EBIT | -2 | |||||
| EV-to-Forward-EBIT | -5.87 | |||||
| EV-to-EBITDA | -2.08 | |||||
| EV-to-Revenue | 4.62 | |||||
| EV-to-Forward-Revenue | 2.09 | |||||
| EV-to-FCF | -10.43 | |||||
| Earnings Yield (Greenblatt) % | -50 | |||||
| FCF Yield % | -22.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SCLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scilex Holding Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 46.743 | ||
| EPS (TTM) ($) | -1.29 | ||
| Beta | 0 | ||
| Volatility % | 122.57 | ||
| 14-Day RSI | 27.27 | ||
| 14-Day ATR ($) | 0.123123 | ||
| 20-Day SMA ($) | 1.21836 | ||
| 12-1 Month Momentum % | -79.97 | ||
| 52-Week Range ($) | 0.8002 - 8.3699 | ||
| Shares Outstanding (Mil) | 106.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scilex Holding Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scilex Holding Co Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Scilex Holding Co Frequently Asked Questions
What is Scilex Holding Co(SCLX)'s stock price today?
The current price of SCLX is $0.88. The 52 week high of SCLX is $8.37 and 52 week low is $0.80.
When is next earnings date of Scilex Holding Co(SCLX)?
The next earnings date of Scilex Holding Co(SCLX) is 2024-05-10 Est..
Does Scilex Holding Co(SCLX) pay dividends? If so, how much?
Scilex Holding Co(SCLX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers